title: Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
authors.forename: M R
authors.initials: MR
authors.lastname: Torrani Cerenzia
authors.forename: L
authors.initials: L
authors.lastname: Fiume
authors.forename: C
authors.initials: C
authors.lastname: Busi
authors.forename: A
authors.initials: A
authors.lastname: Mattioli
authors.forename: G
authors.initials: G
authors.lastname: Di Stefano
authors.forename: G B
authors.initials: GB
authors.lastname: Gervasi
authors.forename: M R
authors.initials: MR
authors.lastname: Brunetto
authors.forename: P
authors.initials: P
authors.lastname: Piantino
authors.forename: G
authors.initials: G
authors.lastname: Verme
authors.forename: F
authors.initials: F
authors.lastname: Bonino
mesh_terms: D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012709:Serum Albumin / Q000494:pharmacology* / Q000627:therapeutic use; D001084:Vidarabine Phosphate / Q000494:pharmacology* / Q000627:therapeutic use; D014779:Virus Replication / Q000187:drug effects*
chemical_list: D012709:Serum Albumin; C046912:lactosaminated serum albumin; D001084:Vidarabine Phosphate